• 1 January 1985
    • journal article
    • research article
    • Vol. 45  (2) , 717-725
Abstract
Amsacrine [m-AMSA; 4''-(9-acridinylamino)methanesulfon-m-anisidide] is a synthetic intercalating agent with clinical utility in the treatment of acute leukemias and lymphomas. As with other intercalators, its mechanism of action is uncertain. Structural changes induced by amsacrine and other intercalators (actinomycin D, Adriamycin, mitoxantrone, 9-aminoacridine) were examined in cultured Chinese hamster (V79-171b) and rat kangaroo kidney epithelial (PtK2) cells, using light microscopy and EM with simultaneous assessment of cell survival. During chronic exposure at low concentrations, amsacrine causes cell and nucleaer enlargement, lobulation of the nucleus and nucleolar segregation. Nucleolar segregation was also induced by the other 4 intercalators. The cytotoxic potency of these drugs, as measured by cell survival after 1-h exposure, was compared with potency of induction of nucleolar segregation. Relative potencies in the 2 assays varied by more than 104-fold, with actinomcyin D the most effective and amsacrine the least effective inducer of nucleolar segregation relative to cytotoxic potency. Although all 5 intercalators induced nucleolar segregation with high specificity, this lesion does not correlate with cell killing by these drugs. However, interference with nucleolar function (i.e., ribosomal RNA synthesis) may be responsible for the reversible cytostatic effect observed on chronic exposure to some intercalators (actinomycin D, 9-aminoacridine) at low concentrations.